{"anticipatedPostingDate":"2028-02","denomUnitsSelected":"Participants","description":"Phase 2: ORR based on RECIST 1.1 or RANO, as Appropriate to Tumor Type","reportingStatus":"NOT_POSTED","timeFrame":"Approximately for up to 9 years 8 months","title":"Phase 2: Overall Response Rate (ORR) Based on RECIST 1.1 or RANO, as Appropriate to Tumor Type","type":"SECONDARY"}